Skip to main content
Year archive

CYNATA THERAPEUTICS LIMITED — 2020 filings

All 78 regulatory filings released by CYNATA THERAPEUTICS LIMITED (CYP) in 2020, sourced directly from the official regulator.

78 Filings
2020 Period
2020 filings (78)
Filing Released Lang
Cleansing Notice 1 page 194.4KB
Capital/Financing Update
2020-12-30 English
2020 Review and Outlook 3 pages 218.1KB
Investor Presentation
2020-12-29 English
Appendix 2A 15 pages 168.5KB
Capital/Financing Update
2020-12-29 English
Becoming a substantial holder 3 pages 682.7KB
Major Shareholding Notification
2020-12-28 English
Cleansing Notice 1 page 194.6KB
Capital/Financing Update
2020-12-23 English
Appendix 2A 15 pages 174.9KB
Capital/Financing Update
2020-12-22 English
Cleansing Notice 1 page 194.4KB
Capital/Financing Update
2020-12-20 English
Cynata Entitlement Offer Opens 2 pages 210.3KB
Capital/Financing Update
2020-12-20 English
Offer Booklet and Entitlement & Acceptance Form 56 pages 12.5MB
Capital/Financing Update
2020-12-20 English
Letter to Ineligible Shareholders 2 pages 278.1KB
Capital/Financing Update
2020-12-20 English
Cynata provides update on Placement and Appendix 2A 16 pages 335.2KB
Capital/Financing Update
2020-12-17 English
Letter to Optionholders 2 pages 240.8KB
Capital/Financing Update
2020-12-14 English
CYP Closes $15m Institutional Placement to Expand Pipeline 4 pages 237.1KB
Capital/Financing Update
2020-12-10 English
Proposed issue of Securities - CYP 10 pages 39.9KB
Capital/Financing Update
2020-12-10 English
Investor Presentation 26 pages 1.0MB
Investor Presentation
2020-12-10 English
Notice Under Section 708AA of the Corporations Act 2 pages 260.2KB
Capital/Financing Update
2020-12-10 English
Trading Halt 2 pages 206.9KB
Capital/Financing Update
2020-12-08 English
Appendix 3G 12 pages 140.3KB
Share Issue/Capital Change
2020-11-29 English
Appendix 3Ys x 5 10 pages 104.7KB
Director's Dealing
2020-11-29 English
AGM Presentations 17 pages 1.8MB
AGM Information
2020-11-23 English
Results of Annual General Meeting 3 pages 194.5KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-23 English
Replacement Constitution 58 pages 660.2KB
Governance Information
2020-11-23 English
Cynata Technology Featured on Front Cover of Nature Medicine 2 pages 211.8KB
Regulatory Filings
2020-11-17 English
Phase 3 Osteoarthritis Clinical Trial Commences 16 pages 1.5MB
Investor Presentation
2020-11-10 English
Quarterly Activity Report & Appendix 4C 9 pages 267.1KB
Interim / Quarterly Report
2020-10-29 English
AusBiotech Conference Presentation 12 pages 1.5MB
Investor Presentation
2020-10-28 English
Letter to Shareholders, Notice of AGM & Proxy Form 37 pages 1.1MB
AGM Information
2020-10-22 English
Annual Report to Shareholders 88 pages 15.6MB
Regulatory Filings
2020-10-22 English
Date of AGM & Closing Date for Director Nominations 1
AGM Information
2020-10-05 English
Potential Utility of Cymerus MSCs in Heart Attack Model 2 pages 212.5KB
Regulatory Filings
2020-09-23 English
Cynata Clinical Trial Results Published in Nature Medicine 2 pages 224.8KB
Regulatory Filings
2020-09-14 English
Appendix 3G 18 pages 281.2KB
Share Issue/Capital Change
2020-09-13 English
Cymerus MSCs Effective in Preclinical Lung Disease Study 2 pages 216.8KB
Regulatory Filings
2020-09-06 English
Appendix 4E & Annual Report 91 pages 2.1MB
Regulatory Filings
2020-08-24 English
Appendix 4G 9 pages 233.7KB
Governance Information
2020-08-24 English
Patient Enrolment Opens in COVID-19 Clinical Trial 1
Regulatory Filings
2020-08-23 English
Appendix 3G 18 pages 264.4KB
Share Issue/Capital Change
2020-08-18 English
Cynata Appoints Dr Geoff Brooke as Chairman 2 pages 217.7KB
Board/Management Information
2020-08-17 English
Cynata Investor Presentation 21 pages 1.7MB
Investor Presentation
2020-08-13 English
Notice of Allowance from Korean Patent Office 2 pages 200.4KB
Regulatory Filings
2020-08-06 English
Notification of Expiry of Unlisted Options 1 page 1
Share Issue/Capital Change
2020-08-04 English
Cynata Announces Positive Results from GvHD Trial Follow-up 2 pages 224.0KB
Regulatory Filings
2020-07-29 English
Quarterly Activity Report & Appendix 4C 9 pages 291.6KB
Interim / Quarterly Report
2020-07-27 English
Notification of Expiry of Unlisted Options 1 page 1
Share Issue/Capital Change
2020-07-19 English
Final Director's Interest Notice 2 pages 28.5KB
Director's Dealing
2020-06-30 English
Securities Dealing Policy 12 pages 179.3KB
Governance Information
2020-06-30 English
Appendix 3Y-Dr Geoff Brooke 2 pages 27.3KB
Director's Dealing
2020-06-23 English
Ethics Approval & Expedited Pathway for Phase 3 OA Trial 2 pages 219.4KB
Regulatory Filings
2020-06-17 English
Block Trade Proceeds to Reduce Director Loans 2 pages 211.0KB
Director's Dealing
2020-06-15 English
Dr Darryl Maher joins Cynata Board 2 pages 214.9KB
Board/Management Information
2020-06-15 English
Appendix 3Y-Stewart Washer 2 pages 26.9KB
Director's Dealing
2020-06-15 English
Appendix 3Y-Ross Macdonald 2 pages 27.2KB
Director's Dealing
2020-06-15 English
Appendix 3X-Darryl Maher 2 pages 31.4KB
Director's Dealing
2020-06-15 English
Investor Presentation 18 pages 1.6MB
Investor Presentation
2020-06-09 English
Appendix 2A 15 pages 174.4KB
Regulatory Filings
2020-06-09 English
Appendix 2A 15 pages 175.0KB
Regulatory Filings
2020-06-01 English
Cynata Successfully Completes Share Purchase Plan 2 pages 178.2KB
Capital/Financing Update
2020-05-26 English
Ethics Approval to Commence Clinical Trial in COVID-19 3 pages 219.9KB
Regulatory Filings
2020-05-07 English
Appendix 2A 15 pages 176.6KB
Capital/Financing Update
2020-04-30 English
Cleansing Notice 1 page 129.9KB
Capital/Financing Update
2020-04-30 English
Share Purchase Plan Booklet 10 pages 175.2KB
Capital/Financing Update
2020-04-29 English
Quarterly Activity Report & Appendix 4C 8 pages 301.4KB
Interim / Quarterly Report
2020-04-23 English
Appendix 2A 15 pages 177.3KB
Capital/Financing Update
2020-04-23 English
Cleansing Notice 1 page 129.3KB
Capital/Financing Update
2020-04-23 English
Proposed Issue of Securities 47 pages 433.7KB
Capital/Financing Update
2020-04-21 English
Cynata announces $5.55m capital raising 3 pages 222.7KB
Capital/Financing Update
2020-04-21 English
Trading Halt 2 pages 250.2KB
Capital/Financing Update
2020-04-19 English
Cynata MSCs beneficial in preclinical ARDS study 2 pages 250.1KB
Regulatory Filings
2020-04-16 English
Cynata provides guidance on planned clinical trials 2 pages 203.7KB
Regulatory Filings
2020-03-31 English
Market Update & Additional A$618k R&D Tax Refund 2 pages 211.4KB
Capital/Financing Update
2020-03-10 English
Cynata Receives Japan Patent Notice of Allowance 2 pages 199.9KB
Regulatory Filings
2020-03-09 English
Canadian Patent Issued for CYP Unique Stem Cell Technology 1
Regulatory Filings
2020-03-02 English
Appendix 4D & Half-Year Financial Statements 24 pages 698.9KB
Interim / Quarterly Report
2020-02-19 English
Notice of Allowance from Israel Patent Office 2 pages 191.9KB
Regulatory Filings
2020-02-05 English
Cynata Investor Presentation 21 pages 1.7MB
Investor Presentation
2020-01-30 English
December 2019 Quarterly Report 8 pages 404.8KB
Interim / Quarterly Report
2020-01-29 English
Cynata Receives UK Regulatory Approval for CLI Trial 2 pages 204.9KB
Regulatory Filings
2020-01-13 English
Cynata Receives $1.892m R&D Tax Incentive Refund 1
Capital/Financing Update
2020-01-06 English